| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10763322 | Biochemical and Biophysical Research Communications | 2011 | 6 Pages |
Abstract
⺠GSH influences the clinical efficacy of Doxorubicin in human leukemic cells. ⺠GSH inhibits the of Doxorubicin-induced p53Ser15 phosphorylation. ⺠GSH also selectively inhibits Doxorubicin-induced caspase dependant Cer generation and apoptosis.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Faisal Thayyullathil, Shahanas Chathoth, Jaleel Kizhakkayil, Alaa Galadari, Abdulkader Hago, Mahendra Patel, Sehamuddin Galadari,